LISATA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
LISATA THERAPEUTICS, INC. (LSTA) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$3.69 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-12
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$3.69M.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$4.36M.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$4.87M.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$11.91M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$3.69M 10-K · filed 2026-03-12 | |
| 2024-12-31 | -$4.36M 10-K · filed 2026-03-12 | |
| 2023-12-31 | -$4.87M 10-K · filed 2025-02-27 | |
| 2022-12-31 | -$11.91M 10-K · filed 2024-02-29 | |
| 2021-12-31 | -$6.08M 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$3.99M 10-K · filed 2022-03-22 | |
| 2019-12-31 | -$4.06M 10-K · filed 2021-02-25 | |
| 2018-12-31 | -$3.40M 10-K · filed 2020-03-05 | |
| 2017-12-31 | -$9.42M 10-K · filed 2019-03-14 | |
| 2016-12-31 | -$10.63M 10-K · filed 2018-03-22 | -$11.28M 10-K · filed 2017-03-17 |
| 2015-12-31 | -$33.41M 10-K · filed 2017-03-17 | |
| 2014-12-31 | -$18.89M 10-K · filed 2016-03-15 | |
| 2013-12-31 | -$13.16M 10-K · filed 2016-03-15 | |
| 2012-12-31 | -$12.33M 10-K · filed 2015-03-02 | |
| 2011-12-31 | -$12.01M 10-K · filed 2013-03-11 | |
| 2010-12-31 | -$8.80M 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |